{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:53:57Z","timestamp":1794092037890,"version":"4.8.0"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Secondary hyperparathyroidism (SHPT) and tertiary hyperparathyroidism (THPT) are common and complicated clinical endocrine diseases. The parathyroid glands maintain endocrine homeostasis by secreting parathyroid hormone to regulate blood calcium levels. However, structural alterations to multiple organs and systems occur throughout the body due to hyperactivity disorder in SHPT and THPT. This not only decreases the patients\u2019 quality of life, but also affects mortality. Since current treatments for these diseases remains unclear, we aimed to develop a comprehensive review of advances in the treatment of SHPT and THPT according to the latest relevant researches.<\/jats:p>","DOI":"10.3389\/fendo.2022.1059828","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:34:57Z","timestamp":1670304897000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Advances in the treatment of secondary and tertiary hyperparathyroidism"],"prefix":"10.3389","volume":"13","author":[{"given":"Li-Xi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"B1","article-title":"Embryology, parathyroid. StatPearls","volume-title":"Treasure island (FL): StatPearls publishing copyright \u00a9 2022","author":"Rosen","year":"2022"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5455\/jpma.302643153","article-title":"Biochemical spectrum of parathyroid disorders diagnosed at a tertiary care setting","volume":"70","author":"Khan","year":"2020","journal-title":"J Pak Med Assoc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy104.fp616","article-title":"[Cholecalciferol supplementation improves secondary hyperparathyroidism control in hemodialysis patients]","volume":"37","author":"Massimetti","year":"2020","journal-title":"G Ital Nefrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nephro.2019.07.328","article-title":"Evolution of secondary hyperparathyroidism in patients following return to hemodialysis after kidney transplant failure","volume":"16","author":"Jannot","year":"2020","journal-title":"Nephrol Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-021-05495-7","article-title":"Secondary hyperparathyroidism among bariatric patients: Unraveling the prevalence of an overlooked foe","volume":"31","author":"Mendon\u00e7a","year":"2021","journal-title":"Obes Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-021-06098-0","article-title":"Preoperative imaging in renal transplant patients with tertiary hyperparathyroidism","volume":"45","author":"Berger","year":"2021","journal-title":"World J Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-020-01095-0","article-title":"Skeletal and mineral metabolic effects of risedronate in a rat model of high-turnover renal osteodystrophy","volume":"38","author":"Ishida","year":"2020","journal-title":"J Bone Miner Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-020-01139-5","article-title":"Relationship between parathyroid hormone and renin-angiotensin-aldosterone system in hemodialysis patients with secondary hyperparathyroidism","volume":"39","author":"Kono","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5710468","article-title":"Parathyroid carcinoma in the setting of tertiary hyperparathyroidism: Case report and review of the literature","volume":"2020","author":"Cappellacci","year":"2020","journal-title":"Case Rep Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102012","article-title":"Parathyroid cancer: An update","volume":"86","author":"Rodrigo","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/a-0723-2807","article-title":"Effects of parathyroidectomy on plasma iPTH and (1-84) PTH levels in patients with stage 5 chronic kidney disease","volume":"50","author":"Huimin","year":"2018","journal-title":"Horm Metab Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90570-7","article-title":"Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure","volume":"25","author":"Tsukamoto","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4646732","article-title":"Sevelamer carbonate crystal-induced colitis","volume":"2020","author":"Lai","year":"2020","journal-title":"Case Rep Gastrointest Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13215","article-title":"Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats","volume":"24","author":"Xiao","year":"2019","journal-title":"Nephrol (Carlton)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1254\/fpj.151.75","article-title":"[Pharmacological, pharmaceutical and clinical profiles of sucroferric oxyhydroxide (P-TOL(\u00ae) chewable tab. 250 mg, 500 mg), a therapeutic agent for hyperphosphatemia]","volume":"151","author":"Tatemichi","year":"2018","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180430","article-title":"PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure","volume":"12","author":"Yaguchi","year":"2017","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2017.05.008","article-title":"Correction of 25-OH-vitamin d deficiency improves control of secondary hyperparathyroidism and reduces the inflammation in stable haemodialysis patients","volume":"38","author":"Ojeda L\u00f3pez","year":"2018","journal-title":"Nefrologia (Engl Ed)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/nu10091164","article-title":"Association of anabolic effect of calcitriol with osteoclast-derived wnt 10b secretion","volume":"10","author":"Lu","year":"2018","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.07960719","article-title":"Conversion from intravenous vitamin d analogs to oral calcitriol in patients receiving maintenance hemodialysis","volume":"15","author":"Thadhani","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-016-1446-1","article-title":"Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients","volume":"49","author":"Rauscher","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s40268-017-0210-z","article-title":"Pharmacokinetics of a new oral vitamin d receptor activator (2-Methylene-19-Nor-(20S)-1\u03b1,25-Dihydroxyvitamin D(3)) in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis","volume":"17","author":"Pandey","year":"2017","journal-title":"Drugs R D"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02175-5","article-title":"Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: An observational study","volume":"51","author":"Koc","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000510360","article-title":"Real world use and effects of calcimimetics in treating mineral and bone disorder in hemodialysis patients","volume":"51","author":"Danese","year":"2020","journal-title":"Am J Nephrol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-jbn-2018-0219","article-title":"The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism","volume":"41","author":"Bucharles","year":"2019","journal-title":"J Bras Nefrol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/17446651.2020.1780911","article-title":"Development of evocalcet for unmet needs among calcimimetic agents","volume":"15","author":"Hamano","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.63.P470","article-title":"Successful management of tertiary hyperparathyroidism associated with hypophosphataemic rickets in an adult","volume":"19","author":"Anagnostis","year":"2019","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000496808","article-title":"Effects of long-term cinacalcet administration on parathyroid gland in hemodialysis patients with secondary hyperparathyroidism","volume":"142","author":"Okuno","year":"2019","journal-title":"Nephron"},{"key":"B28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/imj.14036","article-title":"Outcomes of cinacalcet withdrawal in Australian dialysis patients","volume":"49","author":"Ruderman","year":"2019","journal-title":"Intern Med J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.05.013","article-title":"Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"94","author":"Fukagawa","year":"2018","journal-title":"Kidney Int"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.10.021","article-title":"Pharmacology of parsabiv(\u00ae) (etelcalcetide, ONO-5163\/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients","volume":"842","author":"Harada","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-019-00686-z","article-title":"Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: Predictors, therapeutic approaches and outcomes","volume":"33","author":"Louie","year":"2020","journal-title":"J Nephrol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"18006","DOI":"10.1038\/s41598-021-97587-8","article-title":"The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism","volume":"11","author":"Ngamkam","year":"2021","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/0886022x.2017.1419971","article-title":"Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism","volume":"40","author":"Otsuka","year":"2018","journal-title":"Ren Fail"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02271-6","article-title":"Cinacalcet plus vitamin d versus vitamin d alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: A meta-analysis of randomized controlled trials","volume":"51","author":"Xu","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-017-0319-7","article-title":"Etelcalcetide, a novel calcimimetic, prevents vascular calcification in a rat model of renal insufficiency with secondary hyperparathyroidism","volume":"101","author":"Yu","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26525","article-title":"Effects of FGF-23-mediated ERK\/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism","volume":"233","author":"Chen","year":"2018","journal-title":"J Cell Physiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.08.026","article-title":"Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism","volume":"105","author":"Li","year":"2017","journal-title":"Bone"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw408","article-title":"A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163\/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients","volume":"32","author":"Fukagawa","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/ndt\/gfaa142.p1397","article-title":"[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]","volume":"37","author":"Massimetti","year":"2020","journal-title":"G Ital Nefrol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19468","article-title":"Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: A randomized clinical trial","volume":"317","author":"Block","year":"2017","journal-title":"Jama"},{"key":"B41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.29271\/jcpsp.2020.01.18","article-title":"Outcomes of total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy techniques for secondary hyperparathyroidism in chronic renal failure","volume":"30","author":"Sari","year":"2020","journal-title":"J Coll Physicians Surg Pak"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2019.01.019","article-title":"Subtotal parathyroidectomy vs total parathyroidectomy with autotransplantation for secondary hyperparathyroidism in dialysis patients: Short- and long-term outcomes","volume":"228","author":"Zmijewski","year":"2019","journal-title":"J Am Coll Surg"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2017.09.005","article-title":"Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism","volume":"163","author":"Albuquerque","year":"2018","journal-title":"Surgery"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232428","article-title":"Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism","volume":"15","author":"Sakai","year":"2020","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1159\/000488947","article-title":"Dietary changes involving bifidobacterium longum and other nutrients delays chronic kidney disease progression","volume":"47","author":"Iwashita","year":"2018","journal-title":"Am J Nephrol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1177\/0896860819880095","article-title":"Use of denosumab to treat refractory hypercalcemia in a peritoneal dialysis patient with immobilization and tertiary hyperparathyroidism","volume":"40","author":"Pratt","year":"2020","journal-title":"Perit Dial Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-014-2878-3","article-title":"The utility of neck ultrasound and sestamibi scans in patients with secondary and tertiary hyperparathyroidism","volume":"39","author":"Alkhalili","year":"2015","journal-title":"World J Surg"},{"key":"B48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/ch-190723","article-title":"The role of preoperative ultrasound, contrast-enhanced ultrasound, and 99mTc-MIBI scanning with single-photon emission computed tomography\/X-ray computed tomography localization in refractory secondary hyperparathyroidism","volume":"75","author":"Li","year":"2020","journal-title":"Clin Hemorheol Microcirc"},{"key":"B49","doi-asserted-by":"publisher","first-page":"14634","DOI":"10.1038\/s41598-019-51265-y","article-title":"Pre-operative localisation of the parathyroid glands in secondary hyperparathyroidism: A retrospective cohort study","volume":"9","author":"Hiramitsu","year":"2019","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2021.1904153","article-title":"A short-term non-randomized controlled study of ultrasound-guided microwave ablation and parathyroidectomy for secondary hyperparathyroidism","volume":"38","author":"Zhao","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"B51","first-page":"6","article-title":"A comparative analysis of three types of parathyroidectomies in renal hyperparathyroidism single centre prospective cohort of 77 patients","volume":"92","author":"Neagoe","year":"2021","journal-title":"Ann Ital Chir"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000010816","article-title":"Therapeutic experience of severe and recurrent secondary hyperparathyroidism in a patient on hemodialysis for 18 years: A case report","volume":"97","author":"Zhu","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2018.04.076","article-title":"Total versus subtotal parathyroidectomy for secondary hyperparathyroidism","volume":"165","author":"Isaksson","year":"2019","journal-title":"Surgery"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2017.09.12","article-title":"Near total parathyroidectomy for the treatment of renal hyperparathyroidism","volume":"6","author":"Puccini","year":"2017","journal-title":"Gland Surg"},{"key":"B55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jss.2019.06.020","article-title":"Intraoperative parathyroid hormone monitoring in parathyroidectomy for tertiary hyperparathyroidism","volume":"244","author":"Ermer","year":"2019","journal-title":"J Surg Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40463-017-0238-7","article-title":"Subtotal parathyroidectomy and relocation of the parathyroid remnant for renal hyperparathyroidism: Modification of a traditional operation","volume":"46","author":"Low","year":"2017","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2017.05.062","article-title":"A novel surgical strategy for secondary hyperparathyroidism: Purge parathyroidectomy","volume":"43","author":"Shan","year":"2017","journal-title":"Int J Surg"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2020.08.007","article-title":"Ectopic and supernumerary parathyroid glands in patients with refractory renal hyperparathyroidism","volume":"169","author":"Reitz","year":"2021","journal-title":"Surgery"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/sle.0000000000000727","article-title":"Successful modified transoral endoscopic parathyroidectomy vestibular approach for secondary hyperparathyroidism with ectopic mediastinal glands","volume":"29","author":"Wu","year":"2019","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-020-01861-8","article-title":"Endoscopic parathyroidectomy using a three-port submental approach","volume":"405","author":"Piromchai","year":"2020","journal-title":"Langenbecks Arch Surg"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1038\/s41598-020-60045-y","article-title":"Parathyroid hormone-producing cells exist in adipose tissues surrounding the parathyroid glands in hemodialysis patients with secondary hyperparathyroidism","volume":"10","author":"Kakuta","year":"2020","journal-title":"Sci Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.11817\/j.issn.1672-7347.2017.07.021","article-title":"[Application of carbon nanoparticles suspension injection in uremic patients with secondary hyperparathyroidism underwent total parathyroidectomy: 2 case report and literature review]","volume":"42","author":"Liu","year":"2017","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211000987","article-title":"Intraoperative recurrent laryngeal nerve monitoring using endotracheal electromyography during parathyroidectomy for secondary hyperparathyroidism","volume":"49","author":"Hiramitsu","year":"2021","journal-title":"J Int Med Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"8193","DOI":"10.1038\/s41598-017-08347-6","article-title":"Intraoperative parathyroid localization with near-infrared fluorescence imaging using indocyanine green during total parathyroidectomy for secondary hyperparathyroidism","volume":"7","author":"Cui","year":"2017","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s13304-019-00652-1","article-title":"Intraoperative verification of parathyroid glands in primary and secondary hyperparathyroidism using near-infrared autofluorescence (IOPA)","volume":"71","author":"Wolf","year":"2019","journal-title":"Updates Surg"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/lary.29310","article-title":"Comparison of autofluorescence with near-infrared fluorescence imaging between primary and secondary hyperparathyroidism","volume":"131","author":"Takeuchi","year":"2021","journal-title":"Laryngoscope"},{"key":"B67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1457496919877581","article-title":"Indocyanine green fluorescence angiography can guide intraoperative localization during parathyroid surgery","volume":"110","author":"Di Meo","year":"2021","journal-title":"Scand J Surg"},{"key":"B68","doi-asserted-by":"publisher","first-page":"w20160","DOI":"10.4414\/smw.2019.20160","article-title":"Secondary hyperparathyroidism: Recurrence after total parathyroidectomy with autotransplantation","volume":"149","author":"Steffen","year":"2019","journal-title":"Swiss Med Wkly"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2019.1666724","article-title":"Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism","volume":"41","author":"Zhang","year":"2019","journal-title":"Ren Fail"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1177\/0194599819866819","article-title":"Pattern of intraoperative parathyroid hormone and calcium in the treatment of tertiary hyperparathyroidism","volume":"161","author":"Casarim","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000479616","article-title":"Severe secondary hyperparathyroidism in a hemodialysis patient: A case report from Mongolia","author":"Adiya","year":"2017","journal-title":"Blood Purif"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1159\/000482016","article-title":"Value of intraoperative parathyroid hormone assay during parathyroidectomy in dialysis and renal transplant patients with secondary and tertiary hyperparathyroidism","volume":"138","author":"El-Husseini","year":"2018","journal-title":"Nephron"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02217-y","article-title":"Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism","volume":"51","author":"Ge","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02387-0","article-title":"Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients: Review of an alkaline phosphatase-based treatment protocol","volume":"52","author":"Wong","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12882-019-1416-9","article-title":"Can we predict who will develop postoperative hyperkalaemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism","volume":"20","author":"Song","year":"2019","journal-title":"BMC Nephrol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000009050","article-title":"Total parathyroidectomy with forearm auto-transplantation improves the quality of life and reduces the recurrence of secondary hyperparathyroidism in chronic kidney disease patients","volume":"96","author":"Li","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26604","article-title":"Parathyroidectomy for the treatment of hyperparathyroidism: Thirty-day morbidity and mortality","volume":"128","author":"Tang","year":"2018","journal-title":"Laryngoscope"},{"key":"B78","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40463-017-0226-y","article-title":"PTH monitoring after total parathyroidectomy with forearm auto-transplantation: Potential for spuriously high levels from grafted forearm","volume":"46","author":"Khalil","year":"2017","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0529-5815.2018.06.011","article-title":"[Clinical analysis of reoperation for secondary hyperparathyroidism]","volume":"56","author":"Hua","year":"2018","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"B80","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.1038\/s41598-020-63299-8","article-title":"Efficacy of ultrasound-guided radiofrequency ablation of parathyroid hyperplasia: Single session vs","volume":"10","author":"Zeng","year":"2020","journal-title":"Two-Session Effect Hypocalcemia Sci Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24657","article-title":"Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease","volume":"39","author":"Peng","year":"2017","journal-title":"Head Neck"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2016.1256307","article-title":"Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis","volume":"39","author":"Diao","year":"2017","journal-title":"Ren Fail"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2019.1699965","article-title":"Complications encountered in the treatment of primary and secondary hyperparathyroidism with microwave ablation - a retrospective study","volume":"36","author":"Wei","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2019.1627429","article-title":"Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: A feasibility study","volume":"36","author":"Li","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"B85","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/0886022x.2019.1707097","article-title":"Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism","volume":"42","author":"Ma","year":"2020","journal-title":"Ren Fail"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2020.1785557","article-title":"Hypocalcemia after ultrasound-guided microwave ablation and total parathyroidectomy for secondary hyperparathyroidism: A retrospective study","volume":"37","author":"Wei","year":"2020","journal-title":"Int J Hyperthermia"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2020.0037","article-title":"Minimally invasive treatment for benign parathyroid lesions: Treatment efficacy and safety based on nodule characteristics","volume":"21","author":"Ha","year":"2020","journal-title":"Korean J Radiol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-016-1335-z","article-title":"Feasibility of photodynamic therapy for secondary hyperparathyroidism in chronic renal failure rats","volume":"21","author":"Miyakogawa","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111994","article-title":"Inhibition of autophagy with chloroquine enhanced apoptosis induced by 5-aminolevulinic acid-photodynamic therapy in secondary hyperparathyroidism primary cells and organoids","volume":"142","author":"Zeng","year":"2021","journal-title":"BioMed Pharmacother"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1059828\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:35:02Z","timestamp":1670304902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1059828\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":89,"alternative-id":["10.3389\/fendo.2022.1059828"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1059828","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"article-number":"1059828"}}